Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update.
J Neurol
; 269(12): 6416-6427, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-35908242
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligonucleotides
/
Amyloid Neuropathies, Familial
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Neurol
Year:
2022
Type:
Article
Affiliation country:
United States